Navigation Links
PolyGel Signs Long Term Exclusive Agreement With China's Largest Distributor of Healthcare Products
Date:7/26/2011

WHIPPANY, N.J., July 26, 2011 /PRNewswire/ -- PolyGel, the manufacturer of Orthopedic, Therapy and Skin Care Products, has signed a long term exclusive distribution agreement with China National Pharmaceutical Foreign Trade Corporation (Sinopharm Foreign Trade). Based in Beijing, China, Sinopharm Foreign Trade is a wholly-owned subsidiary of China National Pharmaceutical Group Corporation (SINOPHARM Group).

(Photo:  http://photos.prnewswire.com/prnh/20110726/NY40954 )

The Sinopharm Group is the largest distributor of pharmaceutical and healthcare products in China, with 2010 revenues of over 69.2 billion RMB (approximately $10.45 billion US).

Sinopharm's motto of "Caring for Life-Attending to Health" is a good match for PolyGel's motto of "Improving Well Being". By working together, new Sinopharm/Poly Gel programs and products will be developed and sold into the pharmacy, professional, medical, consumer and Internet market channels across China.

The GDP of China has surpassed Japan to become the second largest economy in the world in 2010. Driven by the continuous increase in national medical and healthcare expenditures, the government's further investment in the medical and healthcare sectors and the effects of medical reform in China, this market will continue to experience rapid growth.

About Diabetes in China

An important part of the PolyGel program will focus on the growing population of diabetics in China. According to a study published in the March 25, 2010 edition of the New England Journal of Medicine, China now has more people with diabetes than any other country in the world, with more than 92 million adults diagnosed with diabetes and another 150 million more are on their way to developing it.

PolyGel's innovative orthopedic and skin care products incorporate proprietary gel formulations, textiles and materials. PolyGel is well known in the United States and Europe as a leading manufacturer of foot care, rehabilitation, sports medicine and consumer healthcare products.  PolyGel core gel materials have been manufactured for over 30 years under the direction of Lawrence Kersen, PolyGel President, and are sold throughout the world.  Quality and consistency are PolyGel hallmarks. When combined with Sinopharm's national distribution network and educational resources, a new level of public and professional awareness will be created to inform both the public and professional communities about the dangers of the diabetic epidemic in China. PolyGel has developed a family of "Diabetic Friendly" products to help minimize potential complications as well as to help treat diagnosed problems.

"Both Sinopharm and PolyGel are very excited about our agreement" said Lawrence Kersen.  "This new partnership gives Sinopharm a supplier of high quality, innovative and cost effective products that will help PolyGel build a strong market presence in this important and growing market, especially in the diabetic area."

For more information on PolyGel, visit our websites at www.polygel.com and www.gelsmart.net.


'/>"/>
SOURCE PolyGel
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. PolyGel® Receives SADMERC Approval for L-Code L3670 for ThermoActive™ Cold & Hot Mobile Compression Shoulder Orthosis
2. PolyGel® Receives SADMERC Approval for L-Code L0627 for New ThermoActive™ Plus Cold & Hot Compression Lumbar Orthosis
3. NSVascular, Inc., a NeuroSigma Subsidiary, Signs an Exclusive License Covering UCLAs Thin-Film Nitinol (TFN) Stent Technology for Endovascular Applications
4. NeoStem Signs Definitive Merger Agreement to Acquire Amorcyte in Equity Transaction
5. Dynatronics Signs Agreement With CHAMPS Group Purchasing
6. Panacea Global, Inc. Signs Multi-year Contract Valued at Minimum $8.75 Million for Cancer Detection System with Palmverse Limited
7. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
8. TPI Signs Macrolide API International Sales and Marketing Agreement
9. Perma-Fix Signs Option Agreement to License Technology for Use in Proprietary Process to Produce Medical Isotopes
10. Hope Paige Designs Medical ID Bracelets Now Available in 1,100 Additional Locations
11. Cancer Research UK Signs Deal With Centella Therapeutics, Inc. to Launch Clinical Development of Radiotherapy-Enhancing Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... 29, 2017   Dynatronics Corporation (NASDAQ: ... of Cynthia L. McHenry (Cyndi) as ... for leading Dynatronics manufacturing, distribution, and purchasing operations ... Dynatronics, CEO Kelvyn H. Cullimore, Jr. ... search process conducted by the company as it ...
(Date:3/29/2017)... , March 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report ... will reach a value of USD 55.8 billion by 2025. The projection ... United States and a more open approach towards cannabis products ... Florida , North Dakota , ...
(Date:3/28/2017)... 2017 The global emerging cancer diagnostics market ... from 2016 to 2023 and reach a figure of ... is a chronic disease and is affecting a huge ... market. This report is focused on emerging cancer diagnostics ... is propelled due to factors such as: increasing number ...
Breaking Medicine Technology:
(Date:3/29/2017)... , ... March 29, 2017 ... ... Alliance (GRMA) is growing as it continues developing an ANSI-approved, consensus-based American ... The organization, which plans to publish the first ANSI-approved GMP standard for ...
(Date:3/29/2017)... , ... March 29, 2017 , ... HealthCareMandA.com will host ... April 20, 2017, at 1:00 PM ET. A recording of the webinar will also ... Webinar Series. , Home health and hospice companies are still popular targets for healthcare ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education ... specialized continuing medical education conference for clinicians who manage some of the most ... York. , The program will be led by co- chairs Dr. John ...
(Date:3/28/2017)... ... March 28, 2017 , ... Tuesday, March 28, 2017, is the ... take the Diabetes Risk Test to find out if they are at risk for ... will light up the evening sky by programming the LAX pylons the color red. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Revolution for Truth has organized ... protect parental rights and civil liberties, and to restore transparency within government agencies ... coincides with a press conference taking place Friday morning calling on President Trump ...
Breaking Medicine News(10 mins):